BioSpace News Archive

Yale School of Medicine announces the initiation of a novel, randomized trial that will test whether receiving PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) for 15 days can improve the health of highly symptomatic adults with Long COVID.

Procyrion, Inc. announced that use of its Aortix™ percutaneous mechanical circulatory support device led to rapid decongestion in a pilot study of patients admitted to the hospital with acute decompensated heart failure and worsening renal function, which is known as cardiorenal syndrome.

BridgeBio Pharma, Inc. today announced the Company’s novel validated muscle tissue-based bioassay, which measures the amount of glycosylated ⍺DG in patients with LGMD2I.

NeuPath Health Inc. is pleased to provide an update with selected preliminary unaudited results for the fourth quarter of 2022 and the full year ended December 31, 2022.

280Bio, Inc. today announced a presentation featuring the Company’s lead development candidate TEB-17231 at the AACR Annual Meeting in Orlando, Florida to be held April 14-19, 2023.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on financial results for the fourth quarter and year ended December 31, 2022, and provide a corporate update, at 8:00 a.m. Eastern Time,